5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Zygomycosis: new trials by email Literature Review of Zygomycosis trials Research Report on Zygomycosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Amphotericin Versus Posaconazole for Pulmonary Mucormycosis Posaconazole 600 mg followed by posaconazole 300 mg once daily, Liposomal Amphotericin B - Mucormycosis; Pulmonary (Etiology) | Phase 2 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 82 | 2022-07-01 | 2026-05-22 |
| World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt debridment - Mucormycosis; Rhinocerebral (Etiology), COVID-19 | Phase 1 / Phase 2 | Completed | Nasser Institute For Research and Treatment | 35 | 2021-05-23 | 2024-02-20 |
| The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study deferasirox, Placebo, Liposomal amphotericin B - Mucormycosis | Phase 2 | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 20 | 2007-10-01 | 2023-10-16 |
| Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis Treatment Liposomal Amphotericin B - Zygomycosis | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 40 | 2007-06-01 | 2026-03-04 |
| PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893) Posaconazole oral suspension - Mycoses | Phase 2 | Completed | Merck Sharp & Dohme LLC | 98 | 2001-01-01 | 2015-12-31 |
Mucormycosis (4) · Aspergillosis (1) · COVID-19 (1) · Candidiasis (1) · Cryptococcosis (1) · Invasive Fungal Infections (1) · Mycoses (1)
Bacterial Infections and Mycoses (5) · Infections (5) · Mycoses (4) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
liposomal amphotericin B (3) · Deferasirox (1) · Dosage Forms (1) · posaconazole (1)
Assistance Publique - Hôpitaux de Paris (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1) · Merck Sharp & Dohme LLC (1) · Nasser Institute For Research and Treatment (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1)
Egypt (1) · France (1) · India (1) · United States (1)
Brad Spellberg, MD (1) · Olivier Lortholary, MD, PhD (1)